[1]

[2]

SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120.

[3]

LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129.

[4]

YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140.

[5]

XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146.

[6]

CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152.

[7]

. [J]. Laboratory Medicine, 2023, 38(12): 1153-1156.

[8]

. [J]. Laboratory Medicine, 2023, 38(12): 1157-1159.

[9]

[10]

YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172.

[11]

DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176.

[12]

GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182.

[13]

. [J]. Laboratory Medicine, 2023, 38(12): 1183-1185.

[14]

. [J]. Laboratory Medicine, 2023, 38(12): 1186-1190.

[15]

. [J]. Laboratory Medicine, 2023, 38(12): 1191-1194.

组别	例数	NK细胞	NK T细胞	单核细胞
感染组	25	18.47±2.04	11.31±1.20^*	14.27±3.73^*
正常对照组	25	16.68±2.30	18.53±1.72	2.81±0.43

组别	例数	NK细胞	NK T细胞	单核细胞
感染组	25	18.47±2.04	11.31±1.20^*	14.27±3.73^*
正常对照组	25	16.68±2.30	18.53±1.72	2.81±0.43

组别	例数	NK细胞	NK T细胞	单核细胞
好转组
治疗前	18	20.00±2.52^*	11.55±1.34	16.39±4.74
治疗后	18	12.65±2.30^#	15.58±1.24^#	23.42±4.18
死亡组
治疗前	7	13.57±1.81	10.55±2.89	7.47±2.81
治疗后	7	12.62±2.32	4.25±0.73	5.50±1.82

组别	例数	NK细胞	NK T细胞	单核细胞
好转组
治疗前	18	20.00±2.52^*	11.55±1.34	16.39±4.74
治疗后	18	12.65±2.30^#	15.58±1.24^#	23.42±4.18
死亡组
治疗前	7	13.57±1.81	10.55±2.89	7.47±2.81
治疗后	7	12.62±2.32	4.25±0.73	5.50±1.82

RichHTML

PDF (PC)

[1]	GAO R,CAO B,HU Y,et a1. Human infection with a novel avian-origin influenza A(H7N9)virus[J]. N Engl J Med,2013,368(20):1888-1897.
[2]	中华人民共和国国家卫生和计划生育委员会. 人感染H7N9禽流感诊疗方案2014年版[J]. 传染病信息,2014,27(1):65-69.
[3]	黄燕,罗二平,朱义玲,等. H7N9禽流感患者外周血T淋巴细胞亚群的分析及临床意义[J]. 浙江临床医学,2015,17(12):2065-2066.
[4]	毛会军,陈戴红,张敏,等. H7N9禽流感患者外周血T淋巴细胞亚群的分析及意义[J]. 检验医学,2013,28(9):758-761.
[5]	JI H,GU Q,CHEN L L,et a1. Epidemiological and clinical characteristics and risk factors for death of patients with avian influenza A H7N9 virus infection from Jiangsu Province,Eastern China[J]. PLoS One,2014,9(3):e89581.
[6]	CHEN Y,LIANG W,YANG S,et al.Human infections with the emerging avian influenza A H7N9 virus from wet market poultry:clinical analysis and characterisation of viral genome[J]. Lancet,2013,381(9881):1916-1925.